Medi-Tech Insights Get in touch

Global Biosimilars Market Size Report Segmented by Product (mAbs, Insulin, G-CSF, Erythropoietin, hGH, Interferons, G-CSF), Application (Oncology, Autoimmune, Diabetes, Blood Disorders, Infectious Diseases, Growth Hormone Deficiency), Manufacturing Type (In-house, Contract) Forecast to 2031

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2026-2027)
  2. Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  3. Executive Summary
    • Biosimilars Market Snapshot (2026-2031)
    • Segment Overview
    • Regional Snapshot
    • Competitive In"4">
    • Market Overview
      • Market Dynamics
        • Drivers
          • Impending patent expiry of blockbuster biologics
          • Cost containment strategies by governments and payers
          • Rising demand for affordable alternatives for costly biologics
          • Strong regulatory support and clear guidelines
          • Increased physician and patient acceptance
        • Restraints
          • Complexity of manufacturing and development
          • Pricing and reimbursement pressures
        • Opportunities
          • Emerging markets expansion
          • Growing pipeline of biosimilars
          • Growing adoption in oncology and chronic disease management
        • Key Market Trends
          • Strategic partnerships and market consolidation
          • Advanced manufacturing technologies
        • Unmet Market Needs
        • Industry Speaks
  • Global Biosimilars Market Size & Forecast (2024-2031), By Product, USD Billion
    • Introduction
    • Monoclonal Antibodies (mAbs)
    • Insulin
    • Granulocyte-Colony Stimulating Factor (G-CSF)
    • Erythropoietin
    • Human Growth Hormone (hGH)
    • Interferons
    • Other Products
  • Global Biosimilars Market Size & Forecast (2024-2031), By Application, USD Billion
    • Introduction
    • Oncology
    • Autoimmune Diseases
    • Diabetes
    • Blood Disorders
    • Growth Hormone Deficiency
    • Infectious Diseases
    • Other Applications
    1. Global Biosimilars Market Size & Forecast (2024-2031), By Manufacturing Type, USD Billion
      • Introduction
      • In-house Manufacturing
      • Contract Manufacturing
    1. Global Biosimilars Market Size & Forecast (2024-2031), By Region, USD Billion
      • Introduction
      • North America Biosimilars Market Size & Forecast (2024-2031), By Country, USD Billion
        • US
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By Manufacturing Type (USD Billion)
        • Canada
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By Manufacturing Type (USD Billion)
      • Europe Biosimilars Market Size & Forecast (2024-2031), By Country, USD Billion
        • UK
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By Manufac(USD Billion)
        • Germany
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By Manufacturing Type (USD Billion)
        • France
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By Manufacturing Type (USD Billion)
        • Italy
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By Manufacturing Type (USD Billion)
        • Spain
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By Manufacturing Type (USD Billion)
        • Rest of Europe
          • Market Size & Forecast, ByUSD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By Manufacturing Type (USD Billion)
      • Asia Pacific (APAC) Biosimilars Market Size & Forecast (2024-2031), By Country, USD Billion
        • China
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By Manufacturing Type (USD Billion)
        • Japan
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By Manufacturing Type (USD Billion)
        • India
          • Market Size & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By Manufacturing Type (USD Billion)
        • Rest of Asia Pacific
          • M & Forecast, By Product (USD Billion)
          • Market Size & Forecast, By Application (USD Billion)
          • Market Size & Forecast, By Manufacturing Type (USD Billion)
      • Latin America (LATAM) Biosimilars Market Size & Forecast (2024-2031), USD Billion
        • Market Size & Forecast, By Product (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By Manufacturing Type (USD Billion)
      • Middle East & Africa (MEA) Biosimilars Market Size & Forecast (2024-2031), USD Billion
        • Market Size & Forecast, By Product (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By Manufacturing Type (USD Billion)
    1. Competitive Landscape
      • Key Players and their Competitive Positioning
        • Key Player Comparison
        • Segment-wise Player Mapping
        • Market Share Analysis (2025)
        • Company Categorization Matrix
          • Dominants/Leaders
          • New Entrants
          • Emerging Players
          • Innovative Players
        • Key Strategies Assessment, By Player (2023-2026)
          • New Product Launch/Approval
          • Partnerships, Agreements, & Collaborations
          • Mergers & Acquisitions
          • Geographic Expansion
    1. Company Profiles*

    (Business Overview, Financial Performance**, Products Offered, Recent Developments)

    • Sandoz Group AG
    • Amgen Inc.
    • Celltrion Inc.
    • Samsung Bioepis
    • Biocon Biologics
    • Pfizer Inc.
    • Fresenius Kabi
    • Viatris Inc.
    • Reddy's Laboratories
    • Teva Pharmaceutical Industries
    • Other Prominent Players

    Note: *Indicative list

    **For listed companies

    Related Reports

    View All Research Reports